Search research articles
Contact Us
Filters
Showing results (101-110 of 163) with videos related to
Page
of 17
Sort By:
International Journal of Cancer
|
December 15, 1980
In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background
K Kärre, G O Klein, R Kiessling, et al.
Nature
|
November 24, 1983
Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1
R C McGarry, S L Helfand, R H Quarles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1981
Selective natural killer resistance in a clone of YAC lymphoma cells
J C Roder, T J Beaumont, R S Kerbel, et al.
Anticancer Research
|
September 1, 1994
Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1
B Shpitz, B J Fernandes, J B Mullen, et al.
European Journal of Immunology
|
April 1, 1979
A functional comparison of tumor cell killing by activated macrophages and natural killer cells
J C Roder, M L Lohmann-Matthes, W Domzig, et al.
Genes, Brain, and Behavior
|
September 16, 2009
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice
V Labrie, W Wang, S W Barger, et al.
Molecular and Cellular Biochemistry
|
June 1, 1984
Human monoclonal antibodies
S P Cole, B G Campling, T Atlaw, et al.
European Journal of Immunology
|
April 1, 1990
Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells
D A Carlow, U Payne, N Hozumi, et al.
The Journal of Clinical Investigation
|
July 1, 1982
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology
T Abo, J C Roder, W Abo, et al.
Cancer Research
|
April 15, 1990
Comparison of cellular immunotherapies and anti-CD3 in the treatment of MCA-38-LD experimental hepatic metastases in C57BL/6 mice
S Gallinger, D W Hoskin, J B Mullen, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 163) with videos related to
Sort By:
Page
of 17
International Journal of Cancer
|
December 15, 1980
In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background
K Kärre, G O Klein, R Kiessling, et al.
Nature
|
November 24, 1983
Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1
R C McGarry, S L Helfand, R H Quarles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1981
Selective natural killer resistance in a clone of YAC lymphoma cells
J C Roder, T J Beaumont, R S Kerbel, et al.
Anticancer Research
|
September 1, 1994
Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1
B Shpitz, B J Fernandes, J B Mullen, et al.
European Journal of Immunology
|
April 1, 1979
A functional comparison of tumor cell killing by activated macrophages and natural killer cells
J C Roder, M L Lohmann-Matthes, W Domzig, et al.
Genes, Brain, and Behavior
|
September 16, 2009
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice
V Labrie, W Wang, S W Barger, et al.
Molecular and Cellular Biochemistry
|
June 1, 1984
Human monoclonal antibodies
S P Cole, B G Campling, T Atlaw, et al.
European Journal of Immunology
|
April 1, 1990
Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells
D A Carlow, U Payne, N Hozumi, et al.
The Journal of Clinical Investigation
|
July 1, 1982
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology
T Abo, J C Roder, W Abo, et al.
Cancer Research
|
April 15, 1990
Comparison of cellular immunotherapies and anti-CD3 in the treatment of MCA-38-LD experimental hepatic metastases in C57BL/6 mice
S Gallinger, D W Hoskin, J B Mullen, et al.
Page
of 17